Statizoid

Lower-middle income (World Bank): statistics and indicators

153 indicators and 4,237 data points for Lower-middle income (World Bank), collected automatically from official statistical sources.

Indicators
153
Data points
4,237

Browse Lower-middle income (World Bank) data by subject

Key indicators for Lower-middle income (World Bank)

IndicatorLatest YearRank Trend
Pertussis - number of reported cases 7,080 2025 10th volatile
Total tetanus - number of reported cases 16,092 2025 3rd volatile
Diphtheria - number of reported cases 20,601 2025 2nd volatile
Measles - number of reported cases 97,321 2025 4th volatile
Neonatal tetanus - number of reported cases 838 2025 4th volatile
Underweight among adults, BMI < 18.5 kg/m2 (crude estimate) 10.6% 2024 4th falling
Overweight among adults, BMI ≥ 25 kg/m2 (crude estimate) 36.3% 2024 8th rising
Obesity among adults, BMI ≥ 30 kg/m2 (age-standardized estimate) 12.0% 2024 8th volatile
Overweight among adults, BMI ≥ 25 kg/m2 (age-standardized estimate) 36.7% 2024 8th rising
Obesity among children and adolescents, BMI-for-age > +2 standard 6.4% 2024 8th volatile
Overweight among children and adolescents, BMI-for-age > +1 standard 14.5% 2024 8th volatile
Obesity among adults, BMI ≥ 30 kg/m2 (crude estimate) 11.8% 2024 7th volatile
Underweight among adults, BMI < 18.5 kg/m2 (age-standardized estimate) 10.5% 2024 4th falling
Thinness among children and adolescents, BMI-for-age < -2 standard 13.5% 2024 2nd falling
Number of infant deaths 2.11 million 2024 2nd falling
Number of under-five deaths 2.78 million 2024 2nd falling
Number of neonatal deaths 1.39 million 2024 2nd falling
Neonatal mortality rate 21.61 2024 4th falling
Infant mortality rate (probability of dying between birth and age 1) 33.08 2024 4th falling
Under-five mortality rate 43.8 2024 3rd falling
Adolescent mortality rate 3.22 2024 3rd falling
Mortality rate for 5-14 year-olds 7.25 2024 3rd falling
Mortality rate among children ages 5 to 9 years 4.05 2024 3rd falling
Number of deaths among adolescents 198,161 2024 2nd falling
Number of deaths among children 5 to 14 years of age 447,816 2024 3rd falling
Number of deaths among children ages 5 to 9 years 249,655 2024 3rd falling
Diabetes treatment coverage, crude 28.94 2022 8th rising
Prevalence of diabetes, age-standardized 19.61 2022 3rd rising
Prevalence of diabetes, crude 18.24 2022 3rd rising
Diabetes treatment coverage, age-standardized 29.83 2022 8th rising
Hib (Hib3) immunization coverage among 1-year-olds (%) 86.0% 2025 4th volatile
Diphtheria tetanus toxoid and pertussis third-dose  (DTP3) 86.0% 2025 6th rising
Measles-containing-vaccine first-dose (MCV1) immunization coverage 85.0% 2025 7th rising
Hepatitis B (HepB3) immunization coverage among 1-year-olds (%) 86.0% 2025 6th rising
Measles-containing-vaccine second-dose (MCV2) immunization coverage 79.0% 2025 6th volatile
Diphtheria tetanus toxoid and pertussis first-dose (DTP1) 90.0% 2025 7th rising
Stunting prevalence among children under 5 years of age (%) 28.9% 2024 4th falling
Stunting numbers among children under 5 years of age (millions) 88,684 2024 4th falling
Overweight numbers among children under 5 years of age (thousands) 12,301 2024 5th rising
Overweight prevalence among children under 5 years of age (%) 4.0% 2024 11th falling
Mean HDL cholesterol, age-standardized 1.1 2018 7th flat
Mean total cholesterol, crude 4.3 2018 7th flat
Mean Non-HDL cholesterol, age-standardized 3.3 2018 6th rising
Mean HDL cholesterol, crude 1.1 2018 7th flat
Mean Non-HDL cholesterol, crude 3.2 2018 8th rising
Mean total cholesterol, age-standardized 4.3 2018 7th flat
BCG immunization coverage among 1-year-olds (%) 88.0% 2025 6th rising
Number of incident tuberculosis cases 6.49 million 2024 2nd falling
Incidence of tuberculosis 208 2024 1st falling
Number of incident tuberculosis cases 234,000 2024 3rd falling
Number of deaths due to tuberculosis, excluding HIV 669,000 2024 2nd falling
Deaths due to tuberculosis among HIV-negative people 21 2024 4th falling
Tuberculosis - new and relapse cases 5.18 million 2024 2nd rising
Tuberculosis treatment coverage 80 2024 3rd rising
Mean BMI (kg/m²) 23 2016 10th rising
Rubella - number of reported cases 4,725 2025 4th volatile
Treatment success rate: new TB cases 90 2023 3rd rising
Yellow fever - number of reported cases 134 2025 6th volatile
UHC Service Coverage sub-index on infectious diseases 67 2023 11th flat
UHC Service Coverage sub-index on service capacity and access 63 2023 10th falling
UHC Service Coverage sub-index on reproductive, maternal, newborn and 66 2023 10th falling
UHC Service Coverage Index 63 2023 10th falling
UHC Service Coverage sub-index on noncommunicable diseases 57 2023 11th flat
Stillbirth rate 16.31 2023 4th falling
Number of women of reproductive age (aged 15-49 years) with anaemia 332,277 2023 4th rising
Rotavirus vaccines completed dose (RotaC) immunization coverage among 70.0% 2025 3rd volatile
Current health expenditure (CHE) as percentage of gross domestic 5.4% 2023 10th rising
External health expenditure (EXT) as percentage of current health 16.7% 2023 3rd rising
Domestic general government health expenditure (GGHE-D) as percentage 40.5% 2023 9th rising
Out-of-pocket expenditure as percentage of current health expenditure 36.6% 2023 4th falling
Domestic general government health expenditure (GGHE-D) as percentage 2.3% 2023 9th rising
Domestic general government health expenditure (GGHE-D) as percentage 7.8% 2023 9th flat
Domestic private health expenditure (PVT-D) as percentage of current 42.8% 2023 4th falling
Current health expenditure (CHE) per capita in US$ 146.96 2023 9th rising
Out-of-pocket expenditure (OOP) per capita in US$ 46.82 2023 9th rising
Domestic private health expenditure (PVT-D) per capita in US$ 57.35 2023 9th rising
Domestic general government health expenditure (GGHE-D) per capita in 64.75 2023 10th rising
Mumps - number of reported cases 65,763 2025 5th volatile
Incidence of tuberculosis (per 100 000 population) 8.1 2023 5th falling
Congenital Rubella Syndrome - number of reported cases 221 2025 6th volatile
External health expenditure (EXT) per capita in US$ 24.86 2023 5th rising
Raised blood pressure (SBP>=140 OR DBP>=90) 28.5 2019 4th falling
Raised blood pressure (SBP>=140 OR DBP>=90) 27.3 2019 6th flat
Hypertension: diagnosis coverage among adults aged 30-79 with 43.1% 2019 8th rising
Hypertension among adults aged 30-79 years, prevalence 33.5 2019 6th rising
Hypertension effective treatment coverage (controlled hypertension) 14.3% 2019 8th volatile
Hypertension: effective treatment coverage (controlled hypertension) 13.9% 2019 8th volatile
Hypertension treatment coverage among adults aged 30-79 with 31.4% 2019 8th rising
Hypertension treatment coverage among adults aged 30-79 with 32.6% 2019 8th rising
Hypertension: diagnosis coverage among adults aged 30-79 with 41.9% 2019 8th rising
Hypertension among adults aged 30-79 years, prevalence, crude 32 2019 7th rising
Pneumococcal conjugate second or third-dose vaccines (PCVc) 81.0% 2025 4th volatile
Treatment success rate: previously treated TB cases 88 2023 2nd rising
Prevalence of insufficient physical activity among adults aged 18+ 37.3% 2022 3rd rising
Prevalence of insufficient physical activity among adults aged 18+ 38.2% 2022 3rd rising
TB patients with known HIV status 84.0% 2024 5th volatile
Confirmed cases of RR-/MDR-TB 89,929 2024 2nd volatile
Tested TB patients HIV-positive 3.6% 2024 8th volatile
New cases tested for RR-/MDR-TB 88.0% 2024 3rd volatile
Age-standardized suicide rates 9.44 2021 6th falling

Share, cite or embed this page

Cite this page

Lower-middle income (World Bank): statistics and indicators. Statizoid, drawing on Statizoid. Retrieved 23 August 2026, from https://statizoid.com/place/lower-middle-income-world-bank/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under the original publishers' licences; please keep the attribution.

<a href="https://statizoid.com/place/lower-middle-income-world-bank/">Lower-middle income (World Bank): statistics and indicators</a> — Statizoid